Menopause is a determinant of breast adipose inflammation

Cancer Prevention Research

Volumn 8, Issue 5, 2015, Pages 349-358

  Iyengar, Neil M ^a,b   Morris, Patrick G ^a   Zhou, Xi Kathy ^b   Gucalp, Ayca ^a,b   Giri, Dilip ^a   Harbus, Michael D ^b   Falcone, Domenick J ^b   Krasne, Margaret D ^a   Vahdat, Linda T ^b   Subbaramaiah, Kotha ^b   Morrow, Monica ^a   Hudis, Clifford A ^a,b   Dannenberg, Andrew J ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE; ESTROGEN;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADULT; AGED; AGING; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE SEVERITY; ESTROGEN SYNTHESIS; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MAJOR CLINICAL STUDY; MENOPAUSE; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; WHITE ADIPOSE TISSUE; ADIPOSE TISSUE; BREAST; COMPLICATION; MASTITIS; MIDDLE AGED; PANNICULITIS; PATHOLOGY; PHYSIOLOGY; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADIPOCYTES; ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST; FEMALE; HUMANS; MASTITIS; MENOPAUSE; MIDDLE AGED; PANNICULITIS; RISK FACTORS; YOUNG ADULT;

EID: 84942022658     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-14-0243     Document Type: Article

References (43)

1. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-44.
2. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7.
3. Iyengar NM, Hudis CA, Dannenberg AJ. Obesity and inflammation: new insights into breast cancer development and progression. Am Soc Clin Oncol Educ Book 2013:46-51.
4. van Kruijsdijk RC, van der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009;18:2569-78.
5. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91.
6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
7. Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B. Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 2008;111:329-42.
8. Petrelli JM, Calle EE, Rodriguez C, Thun MJ. Body mass index, height, and postmenopausal breast cancer mortality in a prospective cohort of US women. Cancer Causes Control 2002;13:325-32.
9. Ewertz M, Jensen MB, Gunnarsdottir KA, Hojris I, Jakobsen EH, Nielsen D, et al. Effect of obesity on prognosis after early-stage breast cancer. J Clin Oncol 2011;29:25-31.
10. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 2010;2010:23.
11. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA 1999;282:2131-5.
12. Hursting SD, Digiovanni J, Dannenberg AJ, Azrad M, Leroith D, Demark-Wahnefried W, et al. Obesity, energy balance, and cancer: new opportunities for prevention. Cancer Prev Res 2012;5:1260-72.
13. Pierce BL, Ballard-Barbash R, Bernstein L, Baumgartner RN, Neuhouser ML, Wener MH, et al. Elevated biomarkers of inflammation are associated with reduced survival among breast cancer patients. J Clin Oncol 2009;27: 3437-44.
14. Bachelot T, Ray-Coquard I, Menetrier-Caux C, Rastkha M, Duc A, Blay JY. Prognostic value of serum levels of interleukin 6 and of serum and plasma levels of vascular endothelial growth factor in hormone-refractory metastatic breast cancer patients. Br J Cancer 2003;88:1721-6.
15. Cleary MP, Grossmann ME. Minireview: obesity and breast cancer: the estrogen connection. Endocrinology 2009;150:2537-42.
16. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 2003;95:1218-26.
17. Iyengar NM, Morris PG, Hudis CA, Dannenberg AJ. Obesity, inflammation, and breast cancer. In: Dannenberg AJ, Berger NA, editors. Obesity, inflammation, and cancer. New York: Springer; 2013. p. 181-217.
18. Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010;72:219-46.
19. Cinti S, Mitchell G, Barbatelli G, Murano I, Ceresi E, Faloia E, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res 2005;46:2347-55.
20. Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell 2014;156:20-44.
21. Murano I, Barbatelli G, Parisani V, Latini C, Muzzonigro G, Castellucci M, et al. Dead adipocytes, detected as crown-like structures, are prevalent in visceral fat depots of genetically obese mice. J Lipid Res 2008;49:1562-8.
22. Subbaramaiah K, Howe LR, Bhardwaj P, Du B, Gravaghi C, Yantiss RK, et al. Obesity is associated with inflammation and elevated aromatase expression in the mouse mammary gland. Cancer Prev Res 2011;4:329-46.
23. Morris PG, Hudis CA, Giri D, Morrow M, Falcone DJ, Zhou XK, et al. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prev Res 2011;4:1021-9.
24. Sun X, Casbas-Hernandez P, Bigelow C, Makowski L, Joseph Jerry D, Smith Schneider S, et al. Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression. Breast Cancer Res Treat 2012;131:1003-12.
25. Silva DC, Costa LO, Vasconcelos AA, Cerqueira JC, Fantato D, Torres DC, et al. Waist circumference and menopausal status are independent predictors of endothelial low-grade inflammation. Endocr Res 2014;39:22-5.
26. Gross AL, Newschaffer CJ, Hoffman-Bolton J, Rifai N, Visvanathan K. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study. Cancer Epidemiol Biomarkers Prev 2013;22:1319-24.
27. Choi EK, Kim WK, Sul OJ, Park YK, Kim ES, Suh JH, et al. TNFRSF14 deficiency protects against ovariectomy-induced adipose tissue inflammation. J Endocrinol 2014;220:25-33.
28. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology Version 3.2014: Breast Cancer 2014; Available from: http://www.nccn.org
29. Morris PG, Zhou XK, Milne GL, Goldstein D, Hawks LC, Dang CT, et al. Increased levels of urinary PGE-M, a biomarker of inflammation, occur in association with obesity, aging, and lung metastases in patients with breast cancer. Cancer Prev Res 2013;6:428-36.
30. Kim S, Taylor JA, Milne GL, Sandler DP. Association between urinary prostaglandin E2 metabolite and breast cancer risk: a prospective, case-cohort study of postmenopausal women. Cancer Prev Res 2013;6:511-8.
31. Nashi N, Kang S, Barkdull GC, Lucas J, Davidson TM. Lingual fat at autopsy. Laryngoscope 2007;117:1467-73.
32. Birkeland KI. [Early insulin therapy in type 2 diabetes?]. Tidsskr Nor Laegeforen 2012;132:2151-2.
33. Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol 2003;21:28-34.
34. Subbaramaiah K, Morris PG, Zhou XK, Morrow M, Du B, Giri D, et al. Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women. Cancer Discov 2012;2:356-65.
35. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
36. Pothiwala P, Jain SK, Yaturu S. Metabolic syndrome and cancer. Metab Syndr Relat Disord 2009;7:279-88.
37. Capasso I, Esposito E, Pentimalli F, Crispo A, Montella M, Grimaldi M, et al. Metabolic syndrome affects breast cancer risk in postmenopausal women: National Cancer Institute of Naples experience. Cancer Biol Ther 2010;10:1240-3.
38. Porto LA, Lora KJ, Soares JC, Costa LO. Metabolic syndrome is an independent risk factor for breast cancer. Arch Gynecol Obstet 2011;284:1271-6.
39. Rosato V, Bosetti C, Talamini R, Levi F, Montella M, Giacosa A, et al. Metabolic syndrome and the risk of breast cancer in postmenopausal women. Ann Oncol 2011;22:2687-92.
40. Xu XJ, Gauthier MS, Hess DT, Apovian CM, Cacicedo JM, Gokce N, et al. Insulin sensitive and resistant obesity in humans: AMPK activity, oxidative stress, and depot-specific changes in gene expression in adipose tissue. J Lipid Res 2012;53:792-801.
41. Kloting N, Fasshauer M, Dietrich A, Kovacs P, Schon MR, Kern M, et al. Insulin-sensitive obesity.Am J Physiol Endocrinol Metab 2010;299:E506-15.
42. Denis GV, Obin MS. 'Metabolically healthy obesity': origins and implications. Mol Aspects Med 2013;34:59-70.
43. Deepa M, Papita M, Nazir A, Anjana RM, Ali MK, Narayan KM, et al. Lean people with dysglycemia have a worse metabolic profile than centrally obese people without dysglycemia. Diabetes Technol Ther 2014;16:91-6.